ClinicalTrials.govpublic full text
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
pancreatic ductal adenocarcinoma, pancreatic cancer, pancreas cancer, metastatic cancer, statin, atorvastatin, lipitor, pcsk9 monoclonal antibody, pcsk9 inhibitor, pcsk9, evolocumab, repatha
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1033649
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.